FHIR CI-Build

This is the Continuous Integration Build of FHIR (will be incorrect/inconsistent at times).
See the Directory of published versions

Example PlanDefinition/opioidcds-10 (Narrative)

Clinical Decision Support Work GroupMaturity Level: N/AStandards Status: InformativeCompartments: No defined compartments

This is the narrative for the resource. See also the XML, JSON or Turtle format. This example conforms to the profile PlanDefinition.


Generated Narrative: PlanDefinition opioidcds-10

StructureDefinition Work Group: cds

identifier: Uniform Resource Identifier (URI)/urn:oid:2.16.840.1.113883.4.642.11.3, cdc-opioid-guidance (use: official, )

version: 0.1.0

name: Cdcopioid10

title: CDC Opioid Prescribing Guideline Recommendation #10

type: ECA Rule

status: draft

date: 2017-04-23

publisher: HL7 International / Clinical Decision Support

contact: http://www.hl7.org/Special/committees/dss

description:

When prescribing opioids for chronic pain, providers should use urine drug testing before starting opioid therapy and consider urine drug testing at least annually to assess for prescribed medications as well as other controlled prescription drugs and illicit drugs.

UseContexts

-CodeValue[x]
* UsageContextType focus: Clinical Focus Medication requested (situation)
* UsageContextType focus: Clinical Focus Chronic pain (finding)

jurisdiction: United States of America

purpose:

CDC’s Guideline for Prescribing Opioids for Chronic Pain is intended to improve communication between providers and patients about the risks and benefits of opioid therapy for chronic pain, improve the safety and effectiveness of pain treatment, and reduce the risks associated with long-term opioid therapy, including opioid use disorder and overdose. The Guideline is not intended for patients who are in active cancer treatment, palliative care, or end-of-life care.

usage:

Providers should be aware if patients are taking other prescription drugs or illicit drugs that might increase their risk of an overdose.

copyright:

© CDC 2016+.

topic: Opioid Prescribing

author: Kensaku Kawamoto, MD, PhD, MHS: , Bryn Rhodes: , Floyd Eisenberg, MD, MPH: , Robert McClure, MD, MPH:

relatedArtifact

library: http://example.org/fhir/Library/opioidcds-recommendation-10

action

Strength of recommendation: Strong

Quality of evidence: Low quality

title: Annual Urine Screening Check

description:

Patient has not had a urine screening in the past 12 months

Documentations

-Type
* documentation

Triggers

-TypeName
* named-event medication-prescribe

condition

kind: applicability

Expressions

-DescriptionLanguageExpression
* Patient has not had a urine screening in the past 12 months text/cql No Screenings in Past Year

dynamicValue

path: activity.extension

Expressions

-LanguageExpression
* text/cql Get Indicator

Actions

-Description
*

Will perform urine screening

*

Not for chronic pain management. Snooze 3 months

action

Strength of recommendation: Strong

Quality of evidence: Low quality

title: Positive Urine Screening Check

description:

Patient has a urine screening testing positive for either unprescribed opioids or illicit drugs in the past 12 months

Documentations

-Type
* documentation

condition

kind: applicability

Expressions

-DescriptionLanguageExpression
* Patient has a positive urine screening in the past 12 months text/cql Has Positive Screening?

action

action

action


 

 

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.